BJP President J.P. Nadda countered Congress President Mallikarjun Kharge’s criticism of the government’s handling of the Manipur unrest. Nadda accused the Congress of pushing a false narrative and blamed their past policies for the current situation. He asserted that the BJP government is committed to restoring peace and highlighted the development work undertaken in the Northeast region.
Posts in category All News
Stock market update: Nifty Pharma index 0.25% in an upbeat market (22-11-2024)
The Nifty Pharma index was trading 0.25 per cent at 21795.10.
LTIMindtree rises 3% after LIC increases stake by 2% via open market (22-11-2024)
LIC increased its shareholding from 1,49,06,665 shares to 2,08,34,009 shares which translates to a shareholding from 5.033 per cent stake to 7.034 per cent
IRM Energy – A new kid on the (listed CGD) block (22-11-2024)
This is legal way of siphoning off without getting into trouble.
This was only concern. But reduced domestic gas production and hence declining cheap APM gas allocation has broken the valuation model of CGD. They ought to settle at lower levels just like OMCs where there is 100% import.
This article explains this.
Typical risk of govt policy dependent businesses.
Stock market update: Sugar stocks up as market rises (22-11-2024)
The 30-share BSE Sensex was up 566.29 points at 77722.08
Bajaj Holdings shares 0.96 per cent in Friday’s trading session (22-11-2024)
The Relative Strength Index of the stock stood at 50.03 on Friday.
HUDCO announces cessation of directors (22-11-2024)
With effect from 21 November 2024
Natco Pharma: Focusing On Complex Products (22-11-2024)
Natco has submitted an ANDA for generic version of Risdiplam – an oral solution for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. The patented drug seems to have done $571mm (~5000 crore INR) of sales in 2023. This patented drug appears to be a competitor to other SMA treatments such as Spinraza and Zolgensma which have sales of approximately $1-1.7 billion in 2023. If Natco’s generic version is approved, it will capture portion of this sales and will potentially improve their topline. If this trend continues, they will be able to offset the potential drop in revlimid sales in the coming years.
Disclosure: Invested
Share market update: Most active stocks of the day in terms of total traded value (22-11-2024)
The NSE Nifty index was trading 191.85 points up at 23541.75